Pathologic stage | Among 123 patients No. (%) | Among 43 RPLN positive patients No. (%) | |
---|---|---|---|
T classification | T0 | 6 (5%) | 5 (12%) |
T1 | 8 (7%) | 5 (12%) | |
T2 | 45 (37%) | 12 (28%) | |
T3 | 20 (16%) | 8 (19%) | |
T4a | 40 (33%) | 10 (23%) | |
T4b | 4 (3%) | 3 (7%) | |
N classification | N0 | 19 (15%) | 1 (2%) |
N1 | 10 (8%) | 3 (7%) | |
N2a | 2 (2%) | 0 | |
N2b | 56 (46%) | 22 (51%) | |
N2c | 30 (24%) | 16 (37%) | |
N3 | 6 (5%) | 1 (2%) | |
TNM stage | I | 1 (1%) | 0 |
II | 7 (6%) | 0 | |
III | 7 (6%) | 0 | |
IVa | 99 (81%) | 38 (88%) | |
IVb | 9 (7%) | 5 (12%) |